BDNF and depressive symptom measurement: We previously reported that pretreatment with SFN or dietary intake of 0.1% glucoraphanin (a precursor for SFN) significantly attenuated depression-like phenotypes and altered BDNF expression in the mPFC and hippocampus of mice with depression-like phenotypes10,11.